APELLIS PHARMACEUTICALS
Apellis Pharmaceuticals is an early-stage biotechnology company focused on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease. The company is leveraging courageous science, creativity, and compassion to deliver life-changing medicines. They aim to develop best-in-class and first-in-class therapies for a broad range of debilitating diseases that are driven by uncontrolled or excessive activation of the complement cascade, including those within hematology, ophthalmology, nephrology, and neurology. It was founded in 2008 and headquartered in Waltham, Massachusetts, United States.
APELLIS PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2008-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.apellis.com
Total Employee:
501+
Status:
Active
Contact:
502-241-4114
Email Addresses:
[email protected]
Total Funding:
643.53 M USD
Technology used in webpage:
Domain Not Resolving HSTS IPv6 ReCAPTCHA Organization Schema Person Schema Google ReCAPTCHA V2 JQuery CDN Microsoft
Similar Organizations
ANI Pharmaceuticals
ANI Pharmaceuticals manufactures oral solid dose products, as well as liquids and topicals.
Cabaletta Bio
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
Circle Pharma
Circle Pharma is a provider of a macrocycle development platform intended to provide macrocyclic peptides.
Cytosorbents
Cytosorbents develops therapeutic devices used in purifying blood to treat life-threatening diseases.
Windtree Therapeutics
Windtree is a clinical-stage focused on developing novel surfactant therapies for respiratory diseases and other potential applications.
Ligand Pharmaceuticals
Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies.
Roivant Sciences
Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.
Tonix Pharmaceuticals
Tonix Pharmaceuticals develops pharmaceutical products for central nervous system disorders.
Viking Therapeutics
Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.
Virta Health
Virta delivers a clinically-proven treatment to reverse type 2 diabetes and other chronic metabolic diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2014-11-20 | Potentia Pharmaceuticals | Potentia Pharmaceuticals acquired by Apellis Pharmaceuticals | N/A |
Investors List
Sixth Street
Sixth Street investment in Post-IPO Debt - Apellis Pharmaceuticals
Solasta Ventures
Solasta Ventures investment in Post-IPO Equity - Apellis Pharmaceuticals
venBio Partners
venBio Partners investment in Series E - Apellis Pharmaceuticals
Epidarex Capital
Epidarex Capital investment in Series E - Apellis Pharmaceuticals
Morningside Venture Investments
Morningside Venture Investments investment in Series E - Apellis Pharmaceuticals
Clough Capital Partners
Clough Capital Partners investment in Series E - Apellis Pharmaceuticals
Sofinnova Investments
Sofinnova Investments investment in Series E - Apellis Pharmaceuticals
Sectoral Asset Management
Sectoral Asset Management investment in Series E - Apellis Pharmaceuticals
F-Prime Capital
F-Prime Capital investment in Series E - Apellis Pharmaceuticals
Vivo Capital
Vivo Capital investment in Series E - Apellis Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2024-03-11 | Apellis Appoints Leading Expert Dr. Philip Ferrone as Chief Medical Retina Advisor |
| 2024-01-22 | Apellis Pharmaceuticals appoints COO |
| 2023-01-05 | Apellis Appoints Leading Retina Specialist Dr. Caroline Baumal as Chief Medical Officer |
Official Site Inspections
http://www.apellis.com Semrush global rank: 1.63 M Semrush visits lastest month: 14.34 K
- Host name: ec2-3-141-146-16.us-east-2.compute.amazonaws.com
- IP address: 3.141.146.16
- Location: Columbus United States
- Latitude: 39.9653
- Longitude: -83.0235
- Metro Code: 535
- Timezone: America/New_York
- Postal: 43215
More informations about "Apellis Pharmaceuticals"
About Apellis - Advancing Treatment by Inhibiting the …
At Apellis, we combine courageous science and compassion to develop life-changing medicines for some of the most challenging diseases patients face. We Advance Courageous Science …See details»
Corporate Giving - Apellis CA
At Apellis, our commitment to developing transformative complement therapies extends beyond discovery and development to fully encompass our vision of being a compassionate …See details»
Corporate Giving - Apellis
At Apellis, our commitment to developing transformative complement therapies extends beyond discovery and development to fully encompass our vision of being a compassionate …See details»
About Apellis - Advancing Treatment by Inhibiting the …
Apellis is a global biopharmaceutical company that develops life-changing therapies. By pioneering targeted C3 therapies, we aim to treat diseases that are driven by excessive activation of the complement cascade, including those …See details»
Apellis Pharmaceuticals - Crunchbase Company Profile …
Apellis Pharmaceuticals is an early-stage biotechnology company focused on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases, with an initial emphasis on diseases of the lungs such …See details»
Apellis Medical Hub Canada
At Apellis, we are committed to developing transformative therapies for people living with a broad range of debilitating diseases by controlling complement, a part of the body’s immune system. …See details»
How to Contact Apellis Pharmaceuticals | Apellis Pharmaceuticals
General inquiries [email protected]. Medical Information Call Center [email protected] (833) 866-3346 (833-TO-MEDINFO) See additional contact information details at apellis.comSee details»
Apellis Pharmaceuticals - LinkedIn
Apellis Pharmaceuticals | 73,122 followers on LinkedIn. Global biopharma company leveraging courageous science, creativity, and compassion to deliver life-changing therapies. | At Apellis, we are ...See details»
Apellis Pharmaceuticals to Present at Upcoming Investor …
5 days ago Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that combines courageous science and compassion to develop life-changing therapies for some of the most …See details»
Corporate Funding - Apellis
Apellis may consider providing support for the following types of Corporate Funding. Donation. A donation is a charitable contribution to a 501(c)(3), not-for-profit organization. The donation is …See details»
Apellis Announces Corporate Restructuring to Drive Growth
Aug 29, 2023 Apellis is aligning the organization to reflect the priorities above, which includes reducing headcount by approximately 225 employees, or approximately 25% of the current …See details»
Paul Fonteyne Joins Apellis Board of Directors
Apr 6, 2020 “Paul is an experienced executive who has successfully run a large organization in the pharmaceutical industry,” said Gerald Chan, Sc.D., Chairman of the Board of Apellis. “His …See details»
About Us - Apellis CA
Apellis Canada. You are now leaving Apellis.ca and being directed to an Apellis site intended for audiences in a different geography. If you continue, the information you are about to access …See details»
Release Details - Apellis Pharmaceuticals, Inc.
Jul 22, 2019 Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds for the treatment of a broad …See details»
Executive Leadership Team at Apellis| Apellis Pharmaceuticals
Meet the leadership team that guides development of targeted C3 therapies to inhibit diseases driven by excessive activation of the complement cascade. The team possesses decades of …See details»
Apellis Pharmaceuticals - Contacts, Employees, Board Members, …
Organization. Apellis Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... Number of Board Member and Advisor Profiles 1. Contacts …See details»
Grants and Giving Requirements - Apellis
The requesting organization’s mission must be aligned with Apellis’ corporate vision and values. For healthcare charitable contributions, grants, and sponsorships, the requesting …See details»
Apellis Pharmaceuticals (APLS) Earnings Date and Reports 2025
Nov 25, 2024 Apellis Pharmaceuticals released Q3 2024 earnings on November 5, 2024, reporting an EPS of -$0.46, which missed the consensus estimate of -$0.32 by $0.14. …See details»
Ophthalmology - Apellis CA
Apellis Canada. You are now leaving Apellis.ca and being directed to an Apellis site intended for audiences in a different geography. If you continue, the information you are about to access …See details»
Investors & Media - Apellis
Join our team of experts working to develop life-changing medicines across a broad range of debilitating diseases. CareersSee details»